Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?

Hepato-Gastroenterology

Volumn 56, Issue 94-95, 2009, Pages 1459-1465

  Vardar, Rukiye ^a   Vardar, Enver ^b   Demir, Sibel ^c   Sayhan, S Emil ^b   Bayol, Ümit ^b   Yildiz, Coşkun ^b   Postaci, Hakan ^c  

^a EGE UNIVERSITY   (Turkey)

^b Izmir Tepecik Training and Research Hospital   (Turkey)

^c Bozyaka Training and Research Hospital   (Turkey)

Author keywords

Aspartate aminotransferase; Chronic viral hepatitis; Liver fibrosis; PLT; y glutamyltranspeptidase

Indexed keywords

ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; MICROSOMAL AMINOPEPTIDASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; KNODELL SCORING SYSTEM; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; THROMBOCYTE COUNT;

ADULT; ALANINE TRANSAMINASE; BIOPSY, NEEDLE; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PLATELET COUNT;

EID: 71949127995     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Wong SN, Lok AS: Update on viral hepatitis: Curr Opin Gastroenterol, 2008; 101:13-18
2. Lok ASF, McMahon BJ: AASLD practice guidelines. Chronic Hepatitis B. Hepatology. 2007; 45(2): 507-539.
3. Stéphane Chevaliez, Jean-Michel Pawlotsky: Hepatitis C Virus Serologic and Virologic Tests and Clinical diagnosis of HCV-Related Liver Disease Review Int J Med Sci 2006; 3:35-40
4. Bravo AA, Sheth SG, Chopra S: Liver biopsy. N Engl J Med 2001; 344:495-500.
5. Giada Sebastiani, Alfredo Alberti: Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy World J Gastroenterol June 21, 2006; 12(23):3682-3694.
6. Karasu Z, Tekin F, Ersoz G, Gunsar F, Batur Y, Ilter T, Akarca US: Liver fibrosis is associated with decreased peripheral platelet count in patient with chronic hepatitis B and C. Dig Dis Sci, 2002; 52:1535-1539. (Pubitemid 46776479)
7. Shin WG, Park SH, Jang MK, Hahn TH, Kim JB, Lee MS, Kim DJ, Jun S-Y, Park CK: Aspartate aminotransferase to platelet index (APRI) can predict hver fibrosis in chronic hepatitis B. Digestive and Liver Disease, 2008; 40:267-274.
8. Lin C-S, Chang C-S, Yang S-S, Yeh H-Z, Lin C-W: Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma. Inter Med, 2008;47:569-575.
9. Fug J, Lai C-L, Fong D Y-T, Yuen J C-H, Wong D K-H, Yuen M-F: Correlation of liver biochemistry with liver stiffness in chronic hepatitis B and development of a predictive model for liver fibrosis. Liver International, 2008;1478-3223.
10. Pan JJ, Yang CF, Chu CJ, Chang FY, Lee SD: Prediction of liver fibrosis in patients with chronic hepatitis B by serum markers. Hepatogastroenterology, 2007;54(77):1503-1506. (Pubitemid 47203457)
11. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-435.
12. Chrysanthos NV, Papatheodoridis GV, Sawas S, Kafiri G, Petraki K, Manesis EK, Archimandritis AJ: Aspartate aminotransferase to platelet ratio index for fibrosis evaluation in chronic viral hepatitis. Europen Journal of Gastroenterology & Hepatology, 2006;18(4):389-396.
13. Piccinino F, Sagnelli E, Pasquale G, Giusti G: Complications following percutaneous liver biopsy. A multicentre retrospective study on 68.276 biopsies. J Hepatol 1986; 2:165-173. (Pubitemid 16125908)
14. Garcia-Tsao G, Boyer JL: Outpatient liver biopsy: how safe is it? Ann Intern Med 1993; 118:150-153.
15. Bedossa P, Dargere D, Paradis V: Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38:1356-1358.
16. Kim DY, Kim SU, Ahn SH, Park JY, Lee JM, Park YN, Yoon KT, Paik YH, Lee KS, Chon CY, Han K-H: Usefulness of FibroScan for detection early compensated liver cirrhosis in chronic hepatitis B. Dig Dis Sci, 2008; 13
17. Wai CT, Greenson JK. Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al: A simple non-invasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38:518-526
18. Wai CT, Cheng CL, Wee A, Dan YY, Chan E, Chua W, et al: Non-invasive models for predicting histology in patients with chronic hepatitis B. Liver Int 2006; 26:666-672 (Pubitemid 43983883)
19. Lebensztejn DM, Skiba E, Sobaniec-otowska M, Burt A, Schuppan D, et al: A simple noninvasive index (APRI) predicts advanced liver fibrosis in children with hepatitis B. Hepatology 2005; 41:1434-1435 (Pubitemid 40770297)
20. Lackner C, Struber G, Liegl B, Paronetto F: Comparison and validation of simple noninvasive tests for predictionof fibrosis in chronic hepatitis C. Hepatology 2005;41:1376-1382 (Pubitemid 40770291)
21. Wang CC, Lim LY, Deubner H, Tapia K, Lau AWY, Manansala J, Krows M, Shuhart MC, Kowdley KV: Factors predictive of significant liver fibrosis in adults with chronic hepatitis B and normal serum ALT. J Clin Gastroenterol, 2008;42(7):820-826.